Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+myeloid cells to promote liver cancer progression
Yang Yang, Tianduo Pei, Chaobao Liu, et al.
Gut (2024), pp. gutjnl-332429
Closed Access | Times Cited: 11

Showing 11 citing articles:

Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Jean‐Ehrland Ricci
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115206-115206
Closed Access | Times Cited: 2
Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1
Lu Li, Jinyun Dong, Chunwei Xu, et al.
Cancer Letters (2025), pp. 217567-217567
Closed Access | Times Cited: 1
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
Yan Liao, Junkai Chen, Hao Yao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
Jiongli Pan, Yi Lin, Xinyuan Liu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Bibliometric analysis of nanoparticle research for diagnostics and therapeutics in hepatocellular carcinoma
Xiaoqing Li, Yue Li, Jingyan Zhu, et al.
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
Liguang Fang, Dandan Gao, Zhe Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hepatocellular carcinoma cells induce γδ T cells through metabolic reprogramming into tumor-progressive subpopulation
Jinkun Xia, Chaoyu Wang, Biao Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Wenhua You, Chupeng Hu, Mengya Zhao, et al.
Gut (2024), pp. gutjnl-333375
Closed Access | Times Cited: 1
Photothermal nanocomposite reactivate “immune-hot” for triple-negative breast cancer treatment via glutamine metabolism reprograming
Yingfeng Cheng, Yanxian Hou, Zhanzheng Ye, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114268-114268
Closed Access | Times Cited: 1
Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Targeting glutamine metabolism crosstalk with tumor immune response
Chenshuang Dong, Yan Zhao, Yecheng Han, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189257-189257
Closed Access | Times Cited: 1
The Q for immune evasion in HCC: ER stress in myeloid cells
Charlotte Rennert, Maike Hofmann
Gut (2024), pp. gutjnl-333249
Open Access
Page 1

Scroll to top